Detailansicht

Wissensnetz

Person

Michael Kreußer (1980-)

Kardiologe

Name	Michael Kreußer
Zeit	1980- (Lebensdaten)
Ort	Heidelberg (Geburtsort) Heidelberg (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med. (Medizinische Fakultät der Univ. Heidelberg) (2006 und 2017)
Beruf	Kardiologe (charakteristischer Beruf) Arzt
Variante	Michael Martin Kreußer Michael M. Kreußer M. M. Kreußer
Beziehung	Universitätsklinikum Heidelberg. Klinik für Kardiologie, Angiologie und Pneumologie (6/2007-12/2021) Nationales Centrum für Tumorerkrankungen Universität Heidelberg. Medizinische Fakultät (Lehrbeauftragter) (9/2017-) Innere Medizin (Thema)
Datensatztyp	Person
GND-Nummer	132382385
Datensatz-ID	132382385
Beteiligt an alle anzeigen Outcomes in patients with cardiac amyloidosis undergoing heart transplantation: the Eurotransplant experience Abfall von Sauerstoffsättigung und Blutdruck sowie Anstieg des zentralen Venendrucks im Rahmen eines Mitralklappenclippings bei einer 81-Jährigen COVID-19 among heart transplant recipients in Germany: a multicenter survey Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients COVID-19 among heart transplant recipients in Germany: a multicenter survey Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis MitraClip implantation followed by insertion of a left ventricular assist device in patients with advanced heart failure Percutaneous mitral valve repair in recurrent severe mitral valve regurgitation after mitral annuloplasty : MitraClip-in-the-ring as a complementary strategy A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis Implementation of an intensified outpatient follow-up protocol improves outcomes in patients with ventricular assist devices A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis Impella 5.0® as bridge-to-recovery short-term mechanical circulatory support after LVAD explantation Implementation of an intensified outpatient follow-up protocol improves outcomes in patients with ventricular assist devices Inpatient therapeutic options Results of concomitant groin-free percutaneous temporary RVAD support using a centrifugal pump with a double-lumen jugular venous cannula in LVAD patients Transient elevation of high-sensitive troponin T after Cardioband implantation Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure The need for dedicated advanced heart failure units to optimize heart failure care: impact of optimized advanced heart failure unit care on heart transplant outcome in high-risk patients Transfemoral aortic valve replacement for severe aortic valve regurgitation in a patient with a pulsatile-flow biventricular assist device Transient elevation of high-sensitive troponin T after Cardioband implantation Inducible cardiomyocyte-specific deletion of CaM kinase II protects from pressure overload-induced heart failure Ca M Kinase II mediates maladaptive post‐infarct remodeling and pro‐inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury Bedeutung der Neurotrophine nerve growth factor und Neurotrophin-3 für die kardiale Noradrenalinhomöostase bei experimenteller Herzinsuffizienz

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Michael Kreußer (1980-)

Outcomes in patients with cardiac amyloidosis undergoing heart transplantation: the Eurotransplant experience

Abfall von Sauerstoffsättigung und Blutdruck sowie Anstieg des zentralen Venendrucks im Rahmen eines Mitralklappenclippings bei einer 81-Jährigen

COVID-19 among heart transplant recipients in Germany: a multicenter survey

Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients

COVID-19 among heart transplant recipients in Germany: a multicenter survey

Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis

MitraClip implantation followed by insertion of a left ventricular assist device in patients with advanced heart failure

Percutaneous mitral valve repair in recurrent severe mitral valve regurgitation after mitral annuloplasty : MitraClip-in-the-ring as a complementary strategy

A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis

Implementation of an intensified outpatient follow-up protocol improves outcomes in patients with ventricular assist devices

A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis

Impella 5.0® as bridge-to-recovery short-term mechanical circulatory support after LVAD explantation

Implementation of an intensified outpatient follow-up protocol improves outcomes in patients with ventricular assist devices

Inpatient therapeutic options

Results of concomitant groin-free percutaneous temporary RVAD support using a centrifugal pump with a double-lumen jugular venous cannula in LVAD patients

Transient elevation of high-sensitive troponin T after Cardioband implantation

Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure

Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure

The need for dedicated advanced heart failure units to optimize heart failure care: impact of optimized advanced heart failure unit care on heart transplant outcome in high-risk patients

Transfemoral aortic valve replacement for severe aortic valve regurgitation in a patient with a pulsatile-flow biventricular assist device

Transient elevation of high-sensitive troponin T after Cardioband implantation

Inducible cardiomyocyte-specific deletion of CaM kinase II protects from pressure overload-induced heart failure

Ca M Kinase II mediates maladaptive post‐infarct remodeling and pro‐inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury

Bedeutung der Neurotrophine nerve growth factor und Neurotrophin-3 für die kardiale Noradrenalinhomöostase bei experimenteller Herzinsuffizienz